William S. Smith Appointed as President of ALR Technologies
18 Abril 2014 - 1:27PM
Marketwired
William S. Smith Appointed as President of ALR Technologies
RICHMOND, VA--(Marketwired - Apr 18, 2014) - ALR Technologies,
Inc. (OTCBB: ALRT) announces today that William S. Smith has been
appointed President of the Company, effective May 19,
2014. Mr. Lawrence Weinstein, who served as President &
COO of ALR Technologies since 2010, expressed a wish to pursue
other activities and will remain as a consultant.
Mr. Smith has served as Director, Commercial Strategies and
External Affairs at ALR Technologies since February
2013. Prior to joining ALRT, he worked at senior levels in the
private sector and in government for more than two decades. He
served as Managing Director at NSI, a Washington-based consulting
firm, whose clients include major pharmaceutical and biotechnology
companies. He spent ten years at Pfizer Inc., where he was Vice
President for U.S. Public Affairs and Policy. In that role, Smith
was the lead advisor on U.S. policy issues to Pfizer's major
commercial businesses in the United States. Smith also ran Pfizer's
state government affairs group, one of the largest such groups in
corporate America. Mr. Smith previously worked in government, where
he was on the staff of two Governors in Massachusetts, was a
leadership aide to the Republican Leadership in the U.S. House of
Representatives, and was a senior aide in the White House Office of
National Drug Control Policy under President George H.W. Bush.
"Larry's experience and knowledge were integral in ALRT
receiving regulatory approvals and putting management systems in
place during the development stage. He was the ideal President
for our company during the critical start-up and will contribute to
the company on an ongoing basis," said Sidney Chan, Chief Executive
Officer of ALR Technologies. "I am pleased to announce that Bill
Smith has agreed to become President. Bill's experience and
skills will be invaluable for the commercialization phase of the
company that we are now entering."
About ALR Technologies
ALR Technologies is a medical device company providing remote
monitoring and care facilitation for patients with chronic
diseases. ALRT has developed the FDA-cleared Health-e-Connect
system which uploads the data from blood glucose meters onto a
secure website where clinicians and others can better monitor and
coordinate the care of these patients. The platform will be
expanded to cover patients with other chronic diseases. More
information on ALR Technologies and its products can be found at
http://www.alrt.com.
This release contains certain "forward-looking statements"
relating to ALR Technologies' business, and these statements
reflect the current views of ALR Technologies with respect to
future events and are subject to certain risks, uncertainties and
assumptions. When used, the words "estimate", "expect",
"anticipate", "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors
that could cause the actual results, performance or achievements of
ALR Technologies and its products to be materially different from
any future results, performances or achievements that may be
expressed or implied by such forward-looking statements. Further
management discussions of risks and uncertainties can be found in
the company's quarterly filings with the Securities and Exchange
Commission.
Contact: Andrew Klips info@alrt.com 859.919.0383
ALR Technologies (QB) (USOTC:ALRT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
ALR Technologies (QB) (USOTC:ALRT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024